Today, about 70% of pharmaceutical products are temperature-sensitive – including tissues, mRNA vaccines, blood and blood components, and cell and gene therapies (CGTs). These products rely on the cold chain, and lapses in that chain, such as poor logistics planning, untrained staff, improper handling, or unsuitable packaging, can lead to wastage, lost revenue, noncompliance, and put patients at risk.
Biotechnology innovation is responsible for the growing prevalence of these life-changing, even life-saving products. According to Statistica, global pharmaceutical cold...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?